Resources and Additional Info

The following is a list of sites and articles with comprehensive information on MS. We encourage you to explore these and other sites, as well as talk to you your doctor to better inform you of your disease.

 National MS Societies

American Academy of Neurology

• https://www.aan.com

Consortium of Multiple Sclerosis Centers

• http://www.mscare.org

Multiple Sclerosis Association of America

• http://www.mymsaa.org

Multiple Sclerosis Foundation

• http://www.msfocus.org

National Institute of Neurological Disorders and Stroke

• http://www.ninds.nih.gov/index.htm

National Multiple Sclerosis Society

• http://www.nationalmssociety.org

 

Frequently Asked Questions

National Multiple Sclerosis Society. Multiple Sclerosis: Frequently Asked Questions.

• http://www.nationalmssociety.org/What-is-MS/MS-FAQ-s#question-What-is-multiple-sclerosis

Multiple Sclerosis Foundation. Multiple Sclerosis FAQs.

• https://msfocus.org/Get-Educated/Common-Questions.aspx

Multiple Sclerosis Association of America. Frequently Asked Questions about Multiple Sclerosis.

• http://www.mymsaa.org/about-ms/faq/

WebMD. Frequently Asked Questions about Multiple Sclerosis. Available at:

• http://www.webmd.com/multiple-sclerosis/guide/multiple-sclerosis-faq

 

Additional Reading

1. Baecher-Allan C, et al. Multiple Sclerosis: Mechanisms and immunotherapy. Neuron. 2018;97(4):742-68. https://www.ncbi.nlm.nih.gov/pubmed/29470968
2. Brownlee W, et al. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017;389(10076):1336-1346. https://www.ncbi.nlm.nih.gov/pubmed/27889190
3. Dargani N, et al. Multiple sclerosis: immunopathology and treatment update. Brain Sci. 2017;7(7):E78. https://www.ncbi.nlm.nih.gov/pubmed/28686222
4. Eriksson I, et al. The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations. Eur J Clin Pharmacol. 2018 Feb 10. [Epub ahead of print]. https://www.ncbi.nlm.nih.gov/pubmed/29429031
5. Karussis D. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun. 2014;48-49:134-42. http://www.ncbi.nlm.nih.gov/pubmed/24524923
6. Marcus JF, et al. Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis. Neurohospitalist 2013;3(2):65-80. http://www.ncbi.nlm.nih.gov/pubmed/23983889
7. Sormani MP, et al. Can we measure long-term treatment effects in multiple sclerosis? Nat Rev Neurol. 2015;11(3):176-82. http://www.nature.com/nrneurol/journal/v11/n3/full/nrneurol.2014.237.html
8. Thompson A, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-73. https://www.ncbi.nlm.nih.gov/pubmed/29275977
9. Toosy A, et al. Symptomatic treatment and management of multiple sclerosis. Handb Clin Neurol.2014;122:513-62. http://www.ncbi.nlm.nih.gov/pubmed/24507534